GEODE CAPITAL MANAGEMENT, LLC - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 31 filers reported holding PYXIS ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q3 2023$573,873
-7.7%
288,299
+18.7%
0.00%
Q2 2023$621,534
-35.2%
242,787
+1.4%
0.00%
Q1 2023$959,797
+351474.0%
239,351
+17.4%
0.00%
Q4 2022$273
-99.9%
203,934
+8.0%
0.00%
Q3 2022$371,000
+42.1%
188,821
+71.9%
0.00%
Q2 2022$261,000
-66.8%
109,847
-43.5%
0.00%
Q1 2022$786,000
-60.5%
194,577
+7.2%
0.00%
Q4 2021$1,990,000181,4720.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,481,662$9,951,4651.48%
Harvest Investment Services, LLC 91,047$365,0980.28%
Tekla Capital Management LLC 708,303$2,840,2950.11%
Laurion Capital Management LP 3,170,803$12,714,9200.09%
Cormorant Asset Management, LP 272,537$1,0930.07%
HHLR ADVISORS, LTD. 530,692$2,128,0750.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 170,295$682,8830.02%
Kingsview Wealth Management, LLC 20,000$80,2000.00%
Point72 Asset Management, L.P. 251,800$1,009,7180.00%
HRT FINANCIAL LP 69,782$2790.00%
View complete list of PYXIS ONCOLOGY INC shareholders